EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Determinants of incidence trends in pancreatic neuroendocrine neoplasms

Giuseppe Lamberti, Elisa Andrini, Adriana Di Odoardo, Arianna Zappi, Claudio Ricci, Davide Campana

Journal of Neuroendocrinology · 2026-02 · 38 (2)

DOI: 10.1111/jne.70136 ↗
AbstractBibliografische Angaben

Abstract

Abstract The incidence of pancreatic neuroendocrine neoplasms (NENs) is rising; whether this reflects a true increase in disease occurrence or improved detection remains uncertain. We conducted a retrospective, population‐based study using data from the Surveillance, Epidemiology, and End Results (SEER) Program (1975–2021) to examine temporal trends in the incidence of pancreatic NENs and assess whether changes reflect improved detection versus a true increase. Incidence trends were stratified by demographic and socioeconomic proxies of healthcare access, including income, residential setting, and race as recorded in SEER at the county level. We identified 16,253 cases of pancreatic NENs (44.6% women; median age 62 years). Incidence increased 7.75‐fold between 1975 and 2021, rising from 0.21 cases per 100,000 population in 1975 to 1.58 per 100,000 in 2021. Median tumour size at diagnosis decreased significantly, with an average annual reduction of 0.73 mm ( R 2 = 0.765; p < 0.001). After adjustment, incidence increased more steeply among men, individuals aged 40–65 years and >65 years (vs.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →